GlassScriptPhysician profile
Max Gehrman
NPI 1861846883
$50,801.59
in general payments reported to CMS, 2019-2025
12 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,325 · 2022: $42K · 2023: $3,709 · 2024: $1,498 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,644 · Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,644.29 |
| Food and Beverage | $1,794.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,147.65 | 2021-2023 | Arthrex |
| Smith+Nephew, INC. | $15,040.37 | 2022 | |
| Peerless Surgical INC. | $4,129.08 | 2022-2025 | |
| Stryker Corporation | $2,230.62 | 2022-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Variax |
| Zimmer Biomet Holdings, INC. | $1,557.82 | 2022 | |
| Novus Surgical Solutions LLC | $1,224.42 | 2021 | |
| Vericel Corporation | $188.13 | 2022-2025 | Maci |
| Medical Device Business Services, INC. | $124.80 | 2021 | |
| Medtronic, INC. | $112.06 | 2023-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $17.57 | 2023 | Excelsiusgps Robotic Navigation System |
| Heron Therapeutics, INC. | $14.84 | 2023 | Aponvie |
| Si-Bone, INC. | $14.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Gehrman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.